NIH-funded research R15 grant

Affordable screening for stroke risk in children with sickle cell disease

Official title: Affordable Shortwave Infrared Spectroscopy for Stroke Risk Screening in Children with Sickle Cell Disease

Funded at Kennesaw State University · NIH-10730967 · Data updated 2026-11-12

This study is looking for a simple and affordable way to check if children with sickle cell disease are at risk for strokes, using a new method that could help catch problems early and keep them safe.

More Stroke research and trials

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionKennesaw State University
NIH-funded
Lab location1 site (Kennesaw, United States)
Project startSeptember 21, 2023
Project endSeptember 20, 2026
Funding year2023
Award (this year)$426,714
NIH project number1R15EB034986-01
Project IDNIH-10730967 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children with sickle cell disease, particularly those living in low-resource settings where current screening methods are not accessible.

Less likely to help

Patients who do not have sickle cell disease or those living in high-resource settings with access to existing screening methods may not benefit from this research.

What this research studies

This research focuses on developing a cost-effective and non-invasive method to screen for stroke risk in children with sickle cell disease (SCD). The current standard screening method, transcranial ultrasound doppler (TCD), is expensive and not widely available in low-resource settings like sub-Saharan Africa. The new approach involves using shortwave infrared spectroscopy to measure cerebral blood flow, which could help identify children at risk for stroke much earlier. By improving access to screening, the research aims to facilitate timely interventions that could prevent strokes in this vulnerable population.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of strokes in children with sickle cell disease by enabling early detection and intervention.

How similar studies have gone: Previous research has shown that innovative screening methods can effectively reduce stroke risk in similar populations, indicating potential success for this novel approach.

Where this research is happening

  • Kennesaw State University
    Kennesaw, United States
    Active

Researchers

  • Principal investigator: Lee, Seung Yup — Kennesaw State University
  • Study coordinator: Lee, Seung Yup

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.